Orally administered dantrolene for prophylaxis of malignant hyperthermia.
D000284:Administration, Oral; D000328:Adult; D003402:Creatine Kinase / Q000097:blood; D003620:Dantrolene / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000008:administration & dosage*
D006827:Hydantoins; D003402:Creatine Kinase; D003620:Dantrolene